Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 23 | 0 | 3 | 0 | €87.50 | €92.71 | 5.954% |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | €123.90 | €137.10 | 10.654% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.63 | €22.78 | 114.255% |
| Icon plc | 15 | 0 | 3 | 0 | €270.50 | €318.32 | 17.678% |
| United Therapeutics | 15 | 0 | 0 | 0 | €223.40 | €289.92 | 29.776% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.14 | €26.01 | 23.020% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €156.05 | €215.54 | 38.121% |
| Ultragenyx Pharmaceutical Inc. | 14 | 1 | 1 | 0 | €39.80 | €85.51 | 114.853% |
| Amedisys Inc. | 13 | 0 | 3 | 0 | €83.50 | €92.26 | 10.491% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €66.00 | €86.72 | 31.389% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €147.50 | €182.96 | 24.041% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.27 | €54.21 | 49.462% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €345.10 | €359.93 | 4.299% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.80 | €247.61 | 16.357% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €19.80 | €31.74 | 60.298% |
| Ensign Group Inc. | 7 | 0 | 0 | 0 | €112.00 | €116.00 | 3.571% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.65 | €65.00 | -3.917% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €98.75 | €110.00 | 11.392% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €78.00 | €97.90 | 25.515% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Taro Pharmaceutical Industries Ltd | 6 | 0 | 0 | 0 | €39.40 | - | - |
| Medpace Holdings Inc | 6 | 0 | 0 | 0 | €349.30 | €399.91 | 14.488% |
| LivaNova plc | 6 | 0 | 2 | 0 | €48.00 | €64.66 | 34.706% |